Lvw Advisors, LLC Amgen Inc Transaction History

Lvw Advisors, LLC

$771 Million
Q3 2024

A detailed history of Lvw Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Lvw Advisors, LLC holds 7,056 shares of AMGN stock, worth $2.08 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

7,056

Previous 7,351 4.01%

Holding current value

$2.08 Million

Previous $2.3 Million 1.0%

% of portfolio

0.29%

Previous 0.34%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$309.38 - $337.38 $91,267 - $99,527	-295 Reduced 4.01%	7,056 $2.27 Million
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $37,047 - $45,022	-141 Reduced 1.88%	7,351 $2.3 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $647,438 - $781,540	-2,408 Reduced 24.32%	7,492 $2.13 Million
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $697,549 - $786,918	-2,728 Reduced 21.6%	9,900 $2.85 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $970,368 - $1.2 Million	-4,438 Reduced 26.0%	12,628 $3.39 Million
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $301,692 - $356,744	-1,408 Reduced 7.62%	17,066 $3.79 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $118,313 - $144,204	524 Added 2.92%	18,474 $4.47 Million
Q4 2022 Jan 18, 2023	SELL	$229.03 - $291.01 $17,635 - $22,407	-77 Reduced 0.43%	17,950 $0
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $81,030 - $91,387	361 Added 2.04%	18,027 $4.06 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $94,591 - $105,263	-410 Reduced 2.27%	17,666 $4.3 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $267,947 - $296,420	1,222 Added 7.25%	18,076 $4.37 Million
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $664,259 - $760,184	3,340 Added 24.72%	16,854 $3.79 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $202,717 - $237,508	955 Added 7.6%	13,514 $2.87 Million
Q2 2021 Jul 15, 2021	BUY	$233.58 - $259.14 $6,306 - $6,996	27 Added 0.22%	12,559 $3.06 Million
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $5,769 - $6,723	-26 Reduced 0.21%	12,532 $3.12 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $20,988 - $24,993	97 Added 0.78%	12,558 $2.89 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $136,097 - $151,351	-580 Reduced 4.45%	12,461 $3.17 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $76,354 - $93,697	386 Added 3.05%	13,041 $3.08 Million
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $277,551 - $368,109	1,523 Added 13.68%	12,655 $2.57 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $7,946 - $10,214	-42 Reduced 0.38%	11,132 $2.68 Million
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $1.43 Million - $1.72 Million	8,236 Added 280.33%	11,174 $2.16 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $489,764 - $574,114	2,938 New	2,938 $541,000
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $202,393 - $228,141	-1,119 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$178.4 - $208.25 $10,704 - $12,495	60 Added 5.67%	1,119 $218,000
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $196,222 - $221,214	1,059 New	1,059 $220,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.

Account